Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

1-800-Flowers Stock: Searching for a Bottom Amid Persistent Headwinds

Dieter Jaworski by Dieter Jaworski
September 1, 2025
in Analysis, Consumer & Luxury, E-Commerce, Earnings, Turnaround
0
1-800-Flowers Stock
0
SHARES
229
VIEWS
Share on FacebookShare on Twitter

Shares of floral and gift delivery service provider 1-800-Flowers.com continue to face significant challenges. The recent confirmation of a “Sell (D-)” rating by Weiss Ratings underscores the persistent concerns weighing on market sentiment. The critical question for investors is whether any hope remains for the beleaguered stock.

Analyst Sentiment Remains Overwhelmingly Negative

Confidence among market analysts is severely lacking. While the consensus rating currently stands at “Hold,” Weiss Ratings reaffirmed its “Sell (D-)” assessment on September 1st. The average price target of $7.50 implies some theoretical upside, yet skepticism clearly dominates the narrative. This bearish view has been echoed by other firms; Noble Financial downgraded the stock from “Strong Buy” to “Hold,” while Wall Street Zen moved to a “Sell” recommendation. The message from experts is unambiguous: they see little potential for positive surprises in the near term.

Disastrous Q3 Earnings Performance

The company’s fiscal third-quarter 2025 results were deeply disappointing across key metrics. Revenue plummeted 12.6% year-over-year to $331.45 million. More alarming was the adjusted loss per share of -$0.71, which fell substantially short of analyst expectations. The earnings report highlighted how rising product and operational costs are significantly compressing profit margins. These figures provide clear evidence of the damage being inflicted by macroeconomic uncertainty, shifting consumer spending habits, and intensifying competitive pressures.

Technical and Fundamental Health Under Pressure

A review of the stock’s technical indicators reveals a pattern of persistent weakness:
* 50-Day Moving Average: $5.60
* 200-Day Moving Average: $5.70
* Year-to-Date Performance: -30.9%

A brief rally occurred on August 22nd, with shares gaining 3.2% following commentary from Fed Chair Powell, but this recovery proved short-lived. The trading session closed with only a marginal gain at $5.40.

Should investors sell immediately? Or is it worth buying 1-800-Flowers?

The company’s balance sheet presents a mixed picture. A Quick Ratio of 0.73 and a Current Ratio of 1.55 point to somewhat strained liquidity, while a Debt-to-Equity Ratio of 0.45 indicates a moderate level of leverage.

One faintly positive signal came from insider activity. Fund 1 Investments increased its position by 19,920 shares on June 24th. This investment, valued at over $100,000, could be interpreted as a vote of confidence—or merely an attempt to average down at a low price point.

Key Data Summary:
* Q3 Revenue: $331.45 million (-12.6% YoY)
* Q3 EPS: -$0.71 (missed consensus)
* Weiss Rating: “Sell (D-)” (confirmed Sept. 1)
* Consensus Rating: “Hold” with $7.50 price target
* Q4 Earnings Date: September 4 (pre-market)

All Eyes on the Upcoming Quarterly Report

The upcoming quarterly report, scheduled for release on September 4 before market open, is now of critical importance. Investors will be scrutinizing whether the company’s “Celebrations Wave” strategy is finally beginning to yield results and if operational improvements can effectively counteract the ongoing margin pressures.

The answers to these questions will likely set the directional course for the stock—not just for the next quarter, but potentially for the long-term future of the entire enterprise.

Ad

1-800-Flowers Stock: Buy or Sell?! New 1-800-Flowers Analysis from December 3 delivers the answer:

The latest 1-800-Flowers figures speak for themselves: Urgent action needed for 1-800-Flowers investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.

1-800-Flowers: Buy or sell? Read more here...

Tags: 1-800-Flowers
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Analysis

Viking Therapeutics Stock: Key Milestone Accelerates Timeline

December 3, 2025
Cogent Biosciences Stock
Analysis

Cogent Biosciences Shares Face Pullback Following Stellar Rally

December 3, 2025
Boeing Stock
Defense & Aerospace

Boeing Shares Surge on Renewed Financial Confidence

December 3, 2025
Next Post
Fisker Registered (A) Stock

Fisker Shareholders Face Total Wipeout as Liquidation Proceeds

Cresud Comercial Industrial Financiera y Agropecuaria CRES Stock

Analyst Downgrade Pressures Cresud Shares Despite Institutional Buying

trivago NV Stock

trivago's AI Strategy Fuels Growth and Market Momentum

Recommended

Biotechnology Trading online

Lexaria Bioscience Corp Announces Registered Direct Offering to Fuel Scientific Advancements

2 years ago
Finance_Banking (2)

Anticipated Earnings Report and Guidance for Cabot

2 years ago
Automotive Trading online

GM Bolsters Battery Development with Strategic Hiring

2 years ago
Amazon Stock

Amazon’s Contradictory Signals: A Battle Between Internal Turmoil and Bullish Analyst Faith

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Boeing Shares Surge on Renewed Financial Confidence

A Legal Avalanche Looms: Kraft Heinz Faces Landmark “Junk Food” Lawsuit

CureVac’s Final Chapter: Shareholders Seal Merger Fate

A Rally on Shaky Ground: The Dow’s Thin Tuesday Gains

Barrick Gold Unveils Radical Restructuring, Shares Hit Decade High

ASML Shares Surge Toward Unprecedented Highs

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics Stock: Key Milestone Accelerates Timeline

by Robert Sasse
December 3, 2025
0

Viking Therapeutics, a clinical-stage biopharmaceutical company, captured significant investor interest this week following its presentation at the...

Nvidia Stock

Nvidia’s Strategic Expansion: Cementing AI Leadership Through Major Investments

December 3, 2025
Cogent Biosciences Stock

Cogent Biosciences Shares Face Pullback Following Stellar Rally

December 3, 2025
Boeing Stock

Boeing Shares Surge on Renewed Financial Confidence

December 3, 2025
Kraft Heinz Stock

A Legal Avalanche Looms: Kraft Heinz Faces Landmark “Junk Food” Lawsuit

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics Stock: Key Milestone Accelerates Timeline
  • Nvidia’s Strategic Expansion: Cementing AI Leadership Through Major Investments
  • Cogent Biosciences Shares Face Pullback Following Stellar Rally

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com